Immunology Investor Event

Abbreviations (Part 1) AD AFRS AI APC BD BiC BLA BOI BP BTKi CINDU CLE CMD CN COPD CPUO CRSSNP CRSWNP CSU DMTA DSQ EASI EoE Eos/hpf EU FcyR FCεR FEV1 FiC Atopic Dermatitis Allergic Fungal Rhinosinusitis Artificial Intelligence antigen-presenting cell Business Development Best In Class biologic license application Business Operating Income Bullous Pemphigoid Bruton tyrosine kinases inhibitor Chronic Inducible Cold Urticaria Cutaneous Lupus Erythematosus capital market day China Chronic Obstructive Pulmonary Disease Chronic Pruritus of Unknown Origin Chronic Rhinosinusitis without Nasal Polyps Chronic Rhinosinusitis with Nasal Polyps Chronic Spontaneous Urticaria Design, Make, Test, Analysis Dysphagia Symptom Questionnaire Eczema Area and Severity Index Eosinophilic Esophagitis Fc (fragment crystallizable)-gamma receptors Eosinophil/high power field European Union Fc-epsilon receptors Forced Expiratory Volume First-in-class FPI HCP HS HSA IBD ICS Ig IGA IgG4-RD IgG4-RD RI IL IPF IRAK4 ISS7 JAK JP kDa LABA LAMA LOE LPI LS LS mean (SE) mAb MoA Nab NBRx NK cell NRDL first patient in HealthCare Partners Hidradenitis Suppurativa human serum albumin Inflammatory Bowel Disease Inhaled corticosteroids immunoglobulin Investigator Global Assessment IgG4-related disease IgG4-RD Responder Index interleukin Idopathic Pulmonary Fibrosis Interleukin-1 receptor-associated kinase 4 Injury Severity Score Janus kinase Japan kilodalton Long-acting beta-agonists Long-acting muscarinic antagonists Loss of Exclusivity Last Patient In Least Squares least square mean (standard error) Monoclonal Antibody Mechanism of Action Nanobody® VHH New-to-brand natural killer cell National Reimbursement Drug List 56 Immunology Investor Event sanofi

View entire presentation